Get Free Delivery With No Minimum Order

AVIALIS 20 MG 1 TAB
- Sku : I-026498
Key features
Avialis 20 mg Film-coated Tablet contains tadalafil 20 mg as its active ingredient. It works by selectively inhibiting phosphodiesterase type 5 (PDE5), helping increase cGMP levels and relax smooth muscle to improve blood flow. It is used for the treatment of pulmonary arterial hypertension (PAH, WHO Group 1) to help improve exercise ability. It is available as a film-coated tablet in a pack of 1 tablet.- Brand: AVIALIS
- Active Ingredient: TADALAFIL 20mg
- Strength: 20mg
- Dosage Form: Film-coated tablet
- Pack Size: 1 Tablet
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Sexual Health
- Pharmacological Group: PDE5 Inhibitors
- Drug Class: PDE5 Inhibitor
- Manufacturer: (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 0909245880
- Shelf Life: 24 months
- Storage: store below 30°c
- Mechanism: PDE5 Inhibitor
- Onset Time: 30-60 minutes
Indications
Approved Uses
Pulmonary Arterial Hypertension (PAH) (WHO Group 1) to improve exercise ability
Dosage & Administration
Dosing by Condition
Pulmonary arterial hypertension: 20 mg once daily; may increase to 40 mg once daily
Maintenance Dose
20 mg once daily for PAH; increase to 40 mg once daily based on individual tolerability
Maximum Dose
Erectile Dysfunction/BPH: 20 mg as needed or 5 mg daily. Pulmonary Arterial Hypertension: 40 mg daily.
Dose Adjustment Notes
Renal impairment: for ED on‑demand, consider lower starting dose in CrCl 30-50 mL/min and limit frequency; in CrCl <30 mL/min or on dialysis, use lower dose and do not exceed 5 mg with extended dosing interval (e.g., not more often than every 72 hours). Once‑daily tadalafil is not recommended in severe renal impairment. Hepatic impairment: mild-moderate-use lower dose/caution; severe hepatic impairment-avoid. Drug interactions: with potent CYP3A4 inhibitors (e.g., ritonavir/ketoconazole/itraconazole/clarithromycin), reduce dose and/or extend interval (e.g., max 10 mg every 72 hours with ritonavir for ED on‑demand); avoid with strong CYP3A4 inducers (e.g., rifampin) due to reduced efficacy.
How to Take
Swallow the 20 mg film‑coated tablet whole with water; may be taken with or without food. For erectile dysfunction (on‑demand), take prior to anticipated sexual activity (commonly at least 30 minutes before); do not take more than one dose in 24 hours.
Side Effects
Common Side Effects
Headache, flushing, dyspepsia, nasal congestion, back pain, myalgia, nasopharyngitis, limb pain
Side Effect Frequency
Common: headache, flushing, dyspepsia, nasal congestion, back pain, myalgia, limb pain, dizziness. Less common/rare but serious: hypotension/syncope, priapism, non‑arteritic anterior ischemic optic neuropathy (sudden vision loss), sudden hearing loss, severe cutaneous reactions (e.g., SJS/TEN).
Safety & Warnings
Contraindications
Contraindicated with: (1) concomitant use of any organic nitrates or nitric oxide donors; (2) concomitant use of guanylate cyclase stimulators (e.g., riociguat); (3) known hypersensitivity to tadalafil or excipients. Additionally, tadalafil should not be used in patients for whom sexual activity is inadvisable due to cardiovascular status (e.g., unstable angina or severe cardiac disease), and is generally avoided in severe hepatic impairment (Child-Pugh C) per labeling/guidelines.
Warnings & Precautions
Key warnings/precautions: assess cardiovascular status and ensure sexual activity is safe; avoid/stop and seek urgent care for chest pain during sexual activity; caution with alpha-blockers/other antihypertensives and with substantial alcohol; counsel to seek urgent care for priapism (>4 hours); discontinue and seek care for sudden vision loss (NAION risk) or sudden hearing loss; use caution in patients with anatomical penile deformity or conditions predisposing to priapism (e.g., sickle cell disease, leukemia, multiple myeloma); caution in severe renal/hepatic impairment; not indicated for use in women for ED.
Drug Interactions
Drug Interactions
Clinically significant interactions include: nitrates/NO donors (contraindicated-profound hypotension), riociguat/guanylate cyclase stimulators (contraindicated-hypotension), history of serious hypersensitivity (contraindicated). Assess cardiovascular status; caution with vasodilatory effects in patients with underlying cardiovascular disease
Interaction Severity
MAJOR/CONTRAINDICATED: nitrates (including recreational nitrites) and guanylate cyclase stimulators (e.g., riociguat) (risk of profound hypotension
Food Interaction
No clinically meaningful food effect; may be taken with or without food.
Special Populations
Kidney Impairment
Mild (CrCl 51-80 mL/min) or moderate (CrCl 31-50 mL/min): Start 20 mg once daily; may increase to 40 mg once daily. Severe (CrCl <30 mL/min or hemodialysis): Avoid use
Liver Impairment
Mild-to-moderate hepatic impairment (Child-Pugh A or B): for erectile dysfunction on-demand use, maximum 10 mg once daily; use with caution. Severe hepatic impairment (Child-Pugh C): use is not recommended (avoid).
Storage & Patient Advice
Monitoring Requirements
No routine laboratory monitoring is required; clinically monitor blood pressure and symptoms of hypotension (especially with antihypertensives/alpha‑blockers), and counsel to seek urgent care for priapism, sudden vision loss (NAION), or sudden hearing loss.
Pharmacology
Mechanism of Action
Selective phosphodiesterase type 5 (PDE5) inhibition increases cGMP in the corpus cavernosum and pulmonary/vascular smooth muscle, enhancing nitric‑oxide-mediated smooth muscle relaxation and blood flow; erectile response requires sexual stimulation.
Product Information
Available Dosage Forms
Film-coated tablet
Composition per Dose
Each film-coated tablet: Tadalafil 20 mg
Generic Availability
Yes
OTC Alternatives
No OTC alternative
Mechanism
PDE5 Inhibitor
Onset Time
30-60 minutes
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)



